|
End-of-day quote
Egyptian Exchange
2026-11-09
|
5-day change | 1st Jan Change | ||
| 385.00 EGP | +1.58% |
|
+45.83% | +504.87% |
| 08-13 | GlaxoSmithKline S.A.E Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 05-17 | GlaxoSmithKline Q1 consol net profit EGP 4.7 million | RE |
Chart: Technical Analysis
Egyptian ExchangeEGP
| Markets | Quality | ||
|---|---|---|---|
Egyptian Exchange
| BIOC | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 425.03 | 550 | 521.01 |
| Spread/Res. | -9.42% | -30.00% | -26.11% |
| Spread/Supp. | +32.44% | +99.99% | +121.42% |
| Support | 290.7 | 192.51 | 173.88 |
- Stock Market
- Stocks
- BIOC Stock
- Charts GlaxoSmithKline S.A.E
Select your edition
All financial news and data tailored to specific country editions
